Dimitri Goundis

Dimitri Goundis was Chief Executive Officer of Acrongenomics, Inc. until September 2, 2008.
He worked for Hoffman La Roche and Speedel AG from 1988 to 2006.
Dr. Goundis served as Senior Director of Project Management for The Medicines Co., Inc. He received a Certificate in Investment Management from the London Business School, a BS in Chemistry/Biochemistry from the University of London and a PhD in Biochemistry from the University of Oxford.